Project Title: “The Role of Ciliated Cells in Preventing Fallopian Tube Cancer Initiation”
Dr. Recouvreux is a postdoctoral fellow at the David Geffen School of Medicine at the University of California, Los Angeles.
Project Title: “A murine model for early ovarian cancer detection using circulating microRNA”
Dr. Elias is an Assistant Professor of Obstetrics, Gynecology and Reproductive Biology at Harvard Medical School and a Gynecologic Oncologist and Director of the Gynecologic Oncology Laboratory at Brigham And Women’s Hospital.
Project Title: “Integrated Analysis of Proteomic and Genomic Signatures in Blood for Early Detection of Ovarian Cancer”
Dr. Patel is an Associate Professor of Therapeutic Radiology at Yale Cancer Center. Dr. Santin is a Professor of Obstetrics, Gynecology, and Reproductive Sciences, the Disease Aligned Research Team Leader, Gynecologic Oncology Program, and Co-Chief, Section of Gynecologic Oncology at Yale Cancer Center. Dr. Patel and Dr. Santin are Co-Principal Investigators on this project.
Project Title: “Biomarker Discovery and Validation in Tissue Proximal Fluids”
Dr. Drapkin is an Associate Professor of Obstetrics, Gynecology and Pathology at the University of Pennsylvania and the Director of the Ovarian Cancer Research Center at Penn Medicine. Dr. Marto is an Associate Professor of Biological Chemistry and Molecular Pharmacology at Harvard Medical School and Director of the Blais Proteomics Center and Principal Investigator for the Department of Cancer Biology at Dana-Farber Cancer Institute. Dr. Drapkin and Dr. Marto are Co-Principal Investigators on this project.
Project Title: “Identification of ovarian cancer biomarkers in women at high risk of developing ovarian cancer using emerging EFIRM Liquid Biopsy (eLB) technology”
Dr. Mok holds the Stephanie C. Stelter Professorship in the Department of Gynecologic Oncology & Reproductive Medicine at The University of Texas MD Anderson Cancer Center.
Project Title: “Clinical Development of an Implantable Nanosensor for Early-Stage Ovarian Cancer Detection”
Dr. Heller is head of the Cancer Nanomedicine Laboratory at Memorial Sloan Kettering. Dr. Long Roche is a gynecologic oncologist at the Memorial Sloan Kettering Cancer Center. Dr. Long Roche and Dr. Heller are Co-Principal Investigators on this project.
Many thanks to Douglas A. Levine, MD, of NYU Perlmutter Cancer Center, for his contributions as Co-PI during the first phase of this project.
